Gene · 6579
Papers2,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytotoxicities of Tumor-Seeking Dyes: Impact on Future Clinical Trials. | ChemMedChem | 2023 | 36630600 | PubTator, text mining | PubMed |
| Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines. | Hepatology | 2023 | 36626642 | PubTator, text mining | PubMed |
| Mathematical models for biomarker calculation of drug-induced liver injury in humans and experimental models based on gadoxetate enhanced magnetic resonance imaging. | PLoS One | 2023 | 36608050 | PubTator, text mining | PubMed |
| Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine. | Clin Transl Sci | 2023 | 36597378 | PubTator, text mining | PubMed |
| [Development of Prediction Methods for Drug-Drug Interactions Based on the Construction of Physiologically Based Pharmacokinetic Models for Hepatic OATP Substrate Drugs and Endogenous Substrates]. | Yakugaku Zasshi | 2023 | 36596534 | PubTator, text mining | PubMed |
| Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy. | Reprod Sci | 2023 | 36595209 | PubTator, text mining | PubMed |
| Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management. | Drug Saf | 2023 | 36522578 | PubTator, text mining | PubMed |
| Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature. | Clin Transl Oncol | 2023 | 36520384 | PubTator, text mining | PubMed |
| Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population. | Mol Biol Rep | 2023 | 36478296 | PubTator, text mining | PubMed |
| Plasma Protein Binding Refinement of the Extended Clearance Classification System: Subclasses for Predicting Hepatic Uptake or Renal Clearance for Classes 1B and 3B. | Eur J Drug Metab Pharmacokinet | 2023 | 36441468 | PubTator, text mining | PubMed |
| Indocyanine green (ICG) fluorescence in robotic hepatobiliary surgery: A systematic review. | Int J Med Robot | 2023 | 36417426 | PubTator, text mining | PubMed |
| Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. | Pharmacogenet Genomics | 2023 | 36373739 | PubTator, text mining | PubMed |
| Management of patients with statin intolerance. | Best Pract Res Clin Endocrinol Metab | 2023 | 36345572 | PubTator, text mining | PubMed |
| Perinatal exposure to UDCA prevents neonatal cholestasis in Cyp2c70-/- mice with human-like bile acids. | Pediatr Res | 2023 | 36151295 | PubTator, text mining | PubMed |
| SPK1/S1P axis confers gastrointestinal stromal tumors (GISTs) resistance of imatinib. | Gastric Cancer | 2023 | 35999321 | PubTator, text mining | PubMed |
| Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid-enhanced liver MRI. | Eur Radiol | 2023 | 35895119 | PubTator, text mining | PubMed |
| Guarding the gate against hyperbilirubinaemia. | Gut | 2023 | 35636922 | PubTator, text mining | PubMed |
| Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH). | Clin Pharmacol Ther | 2023 | 35429164 | PubTator, text mining | PubMed |
| Metabolism-involved drug interactions with traditional Chinese medicines in cardiovascular diseases. | J Food Drug Anal | 2022 | 39666289 | PubTator, text mining | PubMed |
| Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. | Obes Pillars | 2022 | 37990711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6579/papers?page=19